Preferred Label : pneumococcal polysaccharide vaccine;
UMLS semantic type : T121 - Pharmacologic Substance; T129 - Immunologic Factor;
Is substance : O;
Origin ID : M0068580;
UMLS CUI : C0305065;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- Related record
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3605182/fr/prevenar-20-vaccin-pneumococcique-polyosidique-conjugue-20-valent-adsorbe-ou-vpc20-infections-a-pneumocoques
2025
false
false
false
France
evaluation of the transparency committee
preventive immunization/medication
vaccination
pneumococcal infections
prevenar
pneumococcal infectious disease, nos
polysaccharides
pneumococcal polysaccharide vaccine
pneumococcal vaccination
pneumococcal vaccines
vaccines, conjugate
---
https://www.has-sante.fr/jcms/p_3457419/fr/strategie-de-vaccination-contre-les-infections-a-pneumocoque-place-du-vaccin-pneumococcique-polyosidique-conjugue-20-valent-adsorbe-chez-l-adulte
2023
France
public health guidelines
vaccination
Vaccins
adult
Adult
Adult
pneumococcal infections
pneumococcal vaccination
pneumococcal infectious disease, nos
Polysaccharides
adulthood
health planning guidelines
polysaccharides
pneumococcal vaccines
Pneumococcal infection
vaccines, conjugate
vaccination, nos
preventive immunization/medication
pneumococcal polysaccharide vaccine
Vaccinia
vaccination
---
https://www.has-sante.fr/jcms/p_3470387/fr/apexxnar-vaccin-pneumococcique-polyosidique-conjugue-20-valent-adsorbe-infections-a-pneumocoques
2023
false
false
false
France
adult
vaccination
insurance, health, reimbursement
Pneumococcal 20-Valent Conjugate Vaccine
pneumococcus, purified polysaccharides antigen conjugated
Invasive Streptococcus pneumoniae disease (disorder)
vaccine potency
injections, intramuscular
evaluation of the transparency committee
polysaccharides, bacterial
pneumococcal infections
vaccines, conjugate
pneumococcal vaccines
pneumococcal polysaccharide vaccine
---
https://www.has-sante.fr/jcms/p_3468559/fr/vaxneuvance-vaccin-pneumococcique-polyosidique-conjugue-15-valent-adsorbe-streptococcus-pneumoniae-de-6-semaines-a-moins-de-18-ans
2023
false
false
false
France
infant
child
adolescent
insurance, health, reimbursement
vaccine potency
pneumonia, bacterial
otitis
pneumococcal infections
Pneumococcal Conjugate Vaccine
pneumococcus, purified polysaccharides antigen conjugated
vaccination
evaluation of the transparency committee
pneumococcal vaccines
pneumococcal polysaccharide vaccine
polysaccharides, bacterial
streptococcus pneumoniae
vaccines, conjugate
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vaxneuvance
2022
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
vaccination
pneumococcus, purified polysaccharides antigen conjugated
pneumococcal vaccines
vaccines, conjugate
polysaccharides, bacterial
pneumococcal infections
pneumonia, pneumococcal
Invasive Streptococcus pneumoniae disease (disorder)
pneumococcal polysaccharide vaccine
pneumococcal polysaccharide vaccine
Pneumococcal polysaccharide conjugated vaccine (product)
Vaccine Efficacy
Immunogenicity, Vaccine
adult
aged
injections, intramuscular
pregnancy
breast feeding
drug interactions
product surveillance, postmarketing
adjuvants, immunologic
drug evaluation, preclinical
---
